Literature DB >> 12239451

Increased expression of dipeptidyl peptidase IV in human mesothelial cells by malignant ascites from ovarian carcinoma patients.

H Kajiyama1, F Kikkawa, O Maeda, T Suzuki, K Ino, S Mizutani.   

Abstract

Cell surface aminopeptidases play an important role in biological processes through degradation of small peptides. There are many bioactive peptides in ascites and these peptides are involved in carcinoma cell dissemination and infiltration. In human mesothelial cells dipeptidyl peptidase IV (DPPIV) shows the highest expression mostly in four cell surface aminopeptidases: aminopeptidase A, neutral endopeptidase 24-11, aminopeptidase N and DPPIV. Since mesothelial cells are always in contact with ascites, we examined the influence of malignant ascites on DPPIV. DPPIV enzyme activity in mesothelial cells was enhanced by the addition of ascites obtained from ovarian carcinoma patients in a time- and concentration-dependent manner, and flow cytometry and immunocytochemistry also revealed an increased expression of DPPIV on the cell surface of mesothelial cells. The <3-kD fraction of malignant ascites increased the DPPIV enzyme activity to the same level as the total ascites. Northern hybridization demonstrated that DPPIV mRNA was increased 3-fold by the addition of the <3-kD malignant ascites. In conclusion, DPPIV is highly expressed in human mesothelial cells and was regulated by ascites. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239451     DOI: 10.1159/000063801

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  13 in total

1.  Possible involvement of TWIST in enhanced peritoneal metastasis of epithelial ovarian carcinoma.

Authors:  Mikio Terauchi; Hiroaki Kajiyama; Mamoru Yamashita; Mikihiko Kato; Hirohisa Tsukamoto; Tomokazu Umezu; Satoyo Hosono; Eiko Yamamoto; Kiyosumi Shibata; Kazuhiko Ino; Akihiro Nawa; Tetsuro Nagasaka; Fumitaka Kikkawa
Journal:  Clin Exp Metastasis       Date:  2007-05-09       Impact factor: 5.150

2.  Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy.

Authors:  Rosa Barreira da Silva; Melissa E Laird; Nader Yatim; Laurence Fiette; Molly A Ingersoll; Matthew L Albert
Journal:  Nat Immunol       Date:  2015-06-15       Impact factor: 25.606

3.  Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.

Authors:  S Fujiwara; A Nawa; C Luo; M Kamakura; F Goshima; C Kondo; T Kiyono; F Kikkawa; Y Nishiyama
Journal:  Cancer Gene Ther       Date:  2010-10-01       Impact factor: 5.987

4.  Malignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.

Authors:  Akira Yokoi; Yusuke Yoshioka; Yusuke Yamamoto; Mitsuya Ishikawa; Shun-Ichi Ikeda; Tomoyasu Kato; Tohru Kiyono; Fumitaka Takeshita; Hiroaki Kajiyama; Fumitaka Kikkawa; Takahiro Ochiya
Journal:  Nat Commun       Date:  2017-03-06       Impact factor: 14.919

5.  Effects of dipeptidyl peptidase-4 inhibitors on transforming growth factor-β1 signal transduction pathways in the ovarian fibrosis of polycystic ovary syndrome rats.

Authors:  Fang Wang; Zhi-Fen Zhang; Yi-Ran He; Hong-Yan Wu; Shuang-Shuang Wei
Journal:  J Obstet Gynaecol Res       Date:  2018-12-04       Impact factor: 1.730

6.  Dipeptidyl Peptidase 4 Distribution in the Human Respiratory Tract: Implications for the Middle East Respiratory Syndrome.

Authors:  David K Meyerholz; Allyn M Lambertz; Paul B McCray
Journal:  Am J Pathol       Date:  2015-11-18       Impact factor: 4.307

Review 7.  Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer.

Authors:  Soochi Kim; Boyun Kim; Yong Sang Song
Journal:  Cancer Sci       Date:  2016-08-16       Impact factor: 6.716

8.  Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway.

Authors:  Masato Yoshihara; Hiroaki Kajiyama; Akira Yokoi; Mai Sugiyama; Yoshihiro Koya; Yoshihiko Yamakita; Wenting Liu; Kae Nakamura; Yoshinori Moriyama; Hiroaki Yasui; Shiro Suzuki; Yusuke Yamamoto; Carmela Ricciardelli; Akihiro Nawa; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  Int J Cancer       Date:  2020-01-24       Impact factor: 7.396

9.  Combined Treatment with Sodium-Glucose Cotransporter-2 Inhibitor (Canagliflozin) and Dipeptidyl Peptidase-4 Inhibitor (Teneligliptin) Alleviates NASH Progression in A Non-Diabetic Rat Model of Steatohepatitis.

Authors:  Takahiro Ozutsumi; Tadashi Namisaki; Naotaka Shimozato; Kosuke Kaji; Yuki Tsuji; Daisuke Kaya; Yukihisa Fujinaga; Masanori Furukawa; Keisuke Nakanishi; Shinya Sato; Yasuhiko Sawada; Soichiro Saikawa; Koh Kitagawa; Hiroaki Takaya; Hideto Kawaratani; Mitsuteru Kitade; Kei Moriya; Ryuichi Noguchi; Takemi Akahane; Akira Mitoro; Hitoshi Yoshiji
Journal:  Int J Mol Sci       Date:  2020-03-21       Impact factor: 5.923

Review 10.  CD26/dipeptidylpeptidase IV-chemokine interactions: double-edged regulation of inflammation and tumor biology.

Authors:  Anneleen Mortier; Mieke Gouwy; Jo Van Damme; Paul Proost; Sofie Struyf
Journal:  J Leukoc Biol       Date:  2016-01-07       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.